What is polypharmacy?

The concurrent use of multiple medications, which carries risks of drug interactions, adverse effects, and reduced adherence.

Published: 3 April 2026 | Updated: 3 April 2026

Definition

Polypharmacy refers to the use of multiple medications concurrently. While there is no universally agreed threshold, polypharmacy is typically defined as four or more regular medications. In clinical practice, the risk profile increases with each additional medication added.

Polypharmacy itself is not inherently problematic; appropriate polypharmacy occurs when each medication has a clear clinical indication and is necessary for the claimant's medical management. The challenge arises when medications are continued without clear purpose, when drug interactions occur, or when the medication burden becomes too great for the claimant to manage safely.

Types of Polypharmacy

Appropriate Polypharmacy

Occurs when each medication has a clear clinical indication, dosing is appropriate, and the benefits outweigh risks. For example, a claimant with hypertension, diabetes, and heart disease may appropriately require six medications, each with documented necessity.

Inappropriate Polypharmacy

Occurs when medications continue without clear indication, when duplications exist, when drug interactions are problematic, or when the burden of managing multiple medications exceeds the clinical benefit. This is where safety and cost concerns arise.

Excessive Polypharmacy

Refers to the use of more medications than clinically appropriate. This may occur through medication accumulation over time, when multiple prescribers each add medications without awareness of the full regimen, or when deprescribing opportunities are missed.

Why Polypharmacy Matters in Insurance Claims

Polypharmacy has direct implications for your claims:

• Drug interactions increase risk of medication-related hospitalisation and adverse events
• Complex medication regimens reduce adherence, leading to inadequate symptom control
• Higher medication burden increases costs without proportional clinical benefit
• Risk of falls, confusion, and other adverse effects increases with additional medications
• Deprescribing opportunities are missed, leaving claimants on unnecessary medications
• Medication errors and adverse effects complicate rehabilitation and recovery

Common Causes of Inappropriate Polypharmacy

In insurance claims settings, inappropriate polypharmacy often arises from:

• Medication accumulation: Over time, medications are added to manage acute issues but never removed when the issue resolves
• Multiple prescribers without coordination: Each practitioner adds medications without full awareness of the complete regimen
• Failure to deprescribe: Medications continue indefinitely even when no longer indicated
• Incomplete symptom management: Poor pain or mood control leads to additional medications rather than optimisation of existing therapy
• Lack of medication review: Regimens that were appropriate at one stage become inappropriate as the claimant's conditions change
• Duplicate medications: Multiple medications from the same drug class, either intentionally or through lack of awareness

Risks Associated with Polypharmacy

Drug Interactions

The risk of clinically significant drug interactions increases exponentially with the number of medications. A claimant on four medications has a manageable interaction risk; a claimant on ten medications may have dozens of potential interactions. Some interactions are minor, others potentially serious.

Adverse Drug Events

Polypharmacy increases the risk of medication-related adverse effects. Side effects from one medication may be mistaken for a symptom requiring a new medication, creating a cycle where the medication burden grows further.

Non-Adherence

Complex medication regimens are harder to manage. Claimants on multiple medications are more likely to miss doses, take incorrect amounts, or fail to fill prescriptions. This undermines the therapeutic benefit of each medication.

Falls and Injury

Polypharmacy is a significant risk factor for falls, particularly in older claimants. Many medications affect balance, cognition, or blood pressure. The combined effect of multiple medications can substantially increase fall risk.

Medication Errors

As complexity increases, the risk of medication errors increases. Claimants may confuse medications, healthcare providers may miss doses when dispensing multiple drugs, or pharmacists may fail to identify interactions.

Managing Polypharmacy in Your Claims

Effective polypharmacy management involves:

• Regular medication review: At least annually, more frequently if changes occur or if the claimant is on eight or more medications
• Deprescribing: Systematically identifying and removing unnecessary medications
• Prescriber coordination: Ensuring all treating doctors are aware of the complete medication regimen
• Adherence support: Helping claimants manage complex regimens through simplified packaging, reminders, or consultation
• Expert pharmacy input: Engaging pharmacists to assess appropriateness and identify interaction risks
• Ongoing monitoring: Tracking outcomes, adverse effects, and adherence to ensure the regimen remains appropriate

When to Refer for Polypharmacy Assessment

Consider referring for expert pharmacy review if:

• Claimant is on five or more regular medications and has not had medication review in the past 12 months
• Recent hospitalisation or medication-related adverse event has occurred
• Multiple prescribers are involved without coordination
• Medication costs are rising without clear clinical benefit
• Claimant reports confusion or difficulty managing their regimen
• New medication-related adverse effect or interaction is suspected